Evidence map›Paper›PMID 39796755›Full record

ArticleCancers2025

Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence Patterns.

Andreas Zouridis, Ammara Kashif, Ahmed Darwish, Christina Pappa, Federico Ferrari, Sarah Louise Smyth, Negin Sadeghi, Alisha Sattar, Stephen Damato, Mostafa Abdalla and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andreas ZouridisOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.ORCID 0000-0002-1926-5397
Ammara KashifOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Ahmed DarwishOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.ORCID 0000-0001-7562-3534
Christina PappaOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Federico FerrariDepartment of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.ORCID 0000-0001-7065-2432
Sarah Louise SmythOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.ORCID 0000-0001-7407-8247
Negin SadeghiOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Alisha SattarOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.ORCID 0000-0001-7216-3560
Stephen DamatoOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Mostafa AbdallaGuy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Sean KehoeOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Susan AddleyUniversity Hospitals of Derby and Burton NHS Foundation Trust, Derby DE22 3NE, UK.
Hooman Soleymani MajdOxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.ORCID 0000-0003-3293-5321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endometrioid endometrial cancerG2grade 2low grademoderately differentiated

Identifiers

PMID39796755
PMCPMC11719902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.